🟢 Nuvation Bio is trading 4.47% up in after-hours trading with no confirmed company-specific catalyst

Nuvation Bio is trading at $7.25, up +4.47% in after-hours trading, with no confirmed company-specific catalyst.

• It closed at $6.94 on August 26, 2026.
• The latest identifiable developments were the August 20 FDA Fast Track designation for safusidenib and August 6 quarterly results, which are stale explanations for this move.
• Broader market sentiment was positive but insufficient to establish causation.